Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who are receiving the medication guselkumab to treat psoriasis affecting the skin.
- People whose guselkumab doses are given more than 9 weeks apart.
Who may not be able to join:
- People who are receiving guselkumab mainly to treat joint problems (such as psoriatic arthritis) rather than skin psoriasis.
- People whose guselkumab doses were spaced out further apart because of surgery, pregnancy, or an infection.
- People who did not have their psoriasis severity measured (using standard scoring tools called PASI or IGA) at their appointments.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0492036225
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the modalities of guselkumab dose spacing; Psoriasis severity; Duration of guselkumab treatment prior to dose spacing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.